Showing results (31-40 of 43) with videos related to
Sort By:
Pageof 5
Arthritis Research & Therapy|August 8, 2015
MRP8/14 serum levels as a predictor of response to starting and stopping anti-TNF treatment in juvenile idiopathic arthritisJanneke Anink, Lisette W A Van Suijlekom-Smit, Marieke H Otten, et al.Annals of the Rheumatic Diseases|November 12, 2010
Tumour necrosis factor (TNF)-blocking agents in juvenile psoriatic arthritis: are they effective?Marieke H Otten, Femke H M Prince, Rebecca Ten Cate, et al.Arthritis and Rheumatism|February 7, 2003
Radiologic features in juvenile idiopathic arthritis: a first step in the development of a standardized assessment methodMarion A J van Rossum, Aeilko H Zwinderman, Maarten Boers, et al.Arthritis and Rheumatism|September 6, 2005
Development of a standardized method of assessment of radiographs and radiographic change in juvenile idiopathic arthritis: introduction of the Dijkstra composite scoreMarion A J van Rossum, Maarten Boers, Aeilko H Zwinderman, et al.Rheumatology (Oxford, England)|January 7, 2020
MRP8/14 and neutrophil elastase for predicting treatment response and occurrence of flare in patients with juvenile idiopathic arthritisAnouk M Barendregt, Saskia R Veldkamp, Petra C E Hissink Muller, et al.British Journal of Clinical Pharmacology|January 6, 2021
Comprehensive evaluation of microneedle-based intradermal adalimumab delivery vs. subcutaneous administration: results of a randomized controlled clinical trialJustin Jacobse, Wouter Ten Voorde, Anushka Tandon, et al.Rheumatology (Oxford, England)|December 26, 2012
Tumour necrosis factor-blocking agents in persistent oligoarticular juvenile idiopathic arthritis: results from the Dutch Arthritis and Biologicals in Children RegisterJanneke Anink, Marieke H Otten, Femke H M Prince, et al.Arthritis Care & Research|September 12, 2019
Growth and Puberty in Juvenile Dermatomyositis: A Longitudinal Cohort StudyEllen Nordal, Angela Pistorio, Marite Rygg, et al.Annals of the Rheumatic Diseases|June 26, 2012
Effectiveness and safety of a second and third biological agent after failing etanercept in juvenile idiopathic arthritis: results from the Dutch National ABC RegisterMarieke H Otten, Femke H M Prince, Janneke Anink, et al.Annals of the Rheumatic Diseases|March 20, 2014
Trends in prescription of biological agents and outcomes of juvenile idiopathic arthritis: results of the Dutch national Arthritis and Biologics in Children RegisterMarieke H Otten, Janneke Anink, Femke H M Prince, et al.Pageof 5